The presentation focuses on medical oncology (surgery and devices out of scope) and covers:

  • Brief overview on treatment evolution
  • Remaining issues of side effects of immunotherapies
  • Clinician perspective on endpoints (e.g. statistically significant does not mean clinically meaningful)
  • PRO and patients perspectives, evolving health authorities perspective
  • Biomarkers

The speaker uses different examples of oncology trials during the presentation.


  • Professor Martin Fey, Medical Oncologist

Click here for additional information and registration details.


Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.